Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 11.11 is in line with its 1-year average of 10.39, near the high end of its 1-year range (9.67–11.11).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly current ratio; no daily interpolation.
Limited quarterly history available
Current Ratio needs at least three reported quarters before a meaningful chart is shown.
CURRENT RATIO
11.11
CURRENT RATIO AVG TTM
N/A
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.73
median of 864 covered companies
CURRENT VS SECTOR MEDIAN
+198.19%
vs the sector median at left
Market Cap
$1.40B
Current Ratio
17.76
TTM Avg
8.82
3Y Avg
5.82
5Y Avg
10.42
Market Cap
$1.43B
Current Ratio
1.73
TTM Avg
2.42
3Y Avg
2.71
5Y Avg
3.73
Market Cap
$1.43B
Current Ratio
18.31
TTM Avg
12.63
3Y Avg
8.12
5Y Avg
8.12
Market Cap
$1.44B
Current Ratio
3.02
TTM Avg
3.13
3Y Avg
2.94
5Y Avg
3.03
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | $1.41B | 11.11 | N/A | N/A | N/A |
| The Pennant Group, Inc. (PNTG)vs › | $1.41B | 1.20 | 1.17 | 1.13 | 1.04 |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | 17.76 | 8.82 | 5.82 | 10.42 |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 5.61 | 9.29 | 11.65 | 16.84 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | 5.07 | 3.94 | 5.82 | 5.62 |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.43B | 1.73 | 2.42 | 2.71 | 3.73 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.43B | 18.31 | 12.63 | 8.12 | 8.12 |
| Certara, Inc. (CERT)vs › | $1.44B | 2.55 | 2.09 | 2.53 | 2.95 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 3.02 | 3.13 | 2.94 | 3.03 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
Current Ratio
11.11
Quick Ratio
11.11
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 11.11 |
| 2026-03-31 | 9.67 |
